Literature DB >> 28601883

Skin-Homing IL-13-Producing T Cells Expand in the Circulation of Patients with Drug Rash with Eosinophilia and Systemic Symptoms.

Yuichi Teraki1, Tomoo Fukuda.   

Abstract

BACKGROUND: Drug rash with eosinophilia and systemic symptoms (DRESS), also known as drug-induced hypersensitivity syndrome, is characterized by severe drug-induced reactions with extensive cutaneous lesions and visceral involvement. Although T cell-mediated hypersensitivity reactions to drugs may be involved in the pathogenesis of DRESS, there is limited data regarding the T-cell phenotypes responsible for the pathogenesis of DRESS. OBJECTIVE AND METHODS: Using flow cytometry, we investigated the cytokine profiles and cutaneous lymphocyte antigen (CLA) expression in circulating T cells in patients with DRESS.
RESULTS: The proportions of circulating IL-4- and IL-13-producing CD4+ T cells, but not CD8+ T cells, were significantly higher in patients with DRESS during the active stage of the disease than in healthy subjects, and these proportions declined during the recovery stage. No differences in the proportions of circulating IFN-γ-, IL-17-, and IL-22-producing CD4+ and CD8+ T cells were observed between patients with DRESS and healthy subjects. A strong correlation between the proportion of IL-13-producing CD4+ T cells and serum levels of thymus and activation-regulated chemokine was observed. The proportion of CLA-expressing CD4+ T cells was significantly higher during the active stage of the disease. Moreover, the proportion of IL-13-producing CD4+ T cells was higher in the CLA+ subset than in the CLA- subset.
CONCLUSIONS: Skin-homing IL-13-producing CD4+ T cells may be involved in the pathogenesis of DRESS.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Cutaneous lymphocyte antigen; Drug rash with eosinophilia and systemic symptoms; Drug-induced hypersensitivity syndrome; Human herpes virus-6; Interleukin-13; Interleukin-4; T helper 2 cells; Thymus and activation-regulated chemokines

Mesh:

Substances:

Year:  2017        PMID: 28601883     DOI: 10.1159/000475546

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  5 in total

1.  Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing HLA-B*13:01.

Authors:  Jirawat Pratoomwun; Paul Thomson; Kanoot Jaruthamsophon; Rawiporn Tiyasirichokchai; Pimonpan Jinda; Ticha Rerkpattanapipat; Wichittra Tassaneeyakul; Nontaya Nakkam; Pawinee Rerknimitr; Jettanong Klaewsongkram; Yuttana Srinoulprasert; Munir Pirmohamed; Dean J Naisbitt; Chonlaphat Sukasem
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 7.561

Review 2.  Mechanisms of Severe Cutaneous Adverse Reactions: Recent Advances.

Authors:  Teresa Bellón
Journal:  Drug Saf       Date:  2019-08       Impact factor: 5.228

3.  Drug-induced hypersensitivity syndrome with myocardial involvement treated with tofacitinib.

Authors:  William E Damsky; Matthew D Vesely; Alfred Ian Lee; Jaehyuk Choi; Ana-Claire Meyer; Michael Chen; Tariq Ahmad; Brett King
Journal:  JAAD Case Rep       Date:  2019-11-13

Review 4.  Drug Reaction with Eosinophilia and Systemic Symptoms: A Complex Interplay between Drug, T Cells, and Herpesviridae.

Authors:  Luckshman Ganeshanandan; Michaela Lucas
Journal:  Int J Mol Sci       Date:  2021-01-23       Impact factor: 5.923

Review 5.  Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).

Authors:  Fumi Miyagawa; Hideo Asada
Journal:  Int J Mol Sci       Date:  2021-02-21       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.